Elevance Health Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) stock rose 2.44% to $382.23, outperforming competitors like UnitedHealth and Humana during a broader market decline on July 20, 2026. This marked the second consecutive day of gains for Elevance, though it remains 12.38% below its 52-week high. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) rallied 2.44% to $382.23 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
This was the stock's second consecutive day of gains.
Elevance Health Inc. closed 12.38% below its 52-week high of $436.24, which the company achieved on July 14th.
The stock outperformed some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.07% to $421.55, Cigna Group (CI) rose 0.88% to $283.94, and Humana Inc. (HUM) fell 0.45% to $398.20.
Trading volume (1.7 M) remained 73,589 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1641ET